Markets.com Logo

AZN

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1884.0777$
  • Previous Close
    1873.4128$
  • 52 Week Change
    690.34$
  • Day Range
    10.66$
  • 52 Week High/Low
    1205.0183$ - 1895.3577$
  • Dividend Per Share
    0.0017
  • Market cap
    2 886 628 M$
  • EPS
    1.49
  • Beta
    0.192
  • Volume
    --

About

AZN.ST refers to the stock of AstraZeneca PLC traded on the Stockholm Stock Exchange (Nasdaq Stockholm). AstraZeneca is a global pharmaceutical company that develops, manufactures, and commercializes prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, oncology, and infection diseases. The ".ST" suffix is the market identifier code for Nasdaq Stockholm, indicating that the shares are listed and traded on that particular exchange. Investors interested in buying or selling AstraZeneca shares on the Stockholm Stock Exchange would use the AZN.ST symbol to place their orders.

Gold Volatility: Is a Structural Shift Underway? An In-depth Analysis

Noah Lee|--

S&P 500's Record Rally Continues: Nomura Strategist Flags Two Key Exit Signals

Liam James|--

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Factors

Drug Development and Clinical Trial Results: Positive outcomes in clinical trials, FDA approvals, and successful drug launches typically boost the stock price, while failures or delays can negatively impact it. Pharmaceutical Industry Trends: Overall industry growth, technological advancements, and shifts in regulatory landscapes can affect investor sentiment and AZN.ST's valuation. Competition: The emergence of new competitors or generic versions of existing drugs can decrease AZN.ST's market share and profitability, leading to price declines. Economic Conditions: Global economic downturns or recessions can reduce healthcare spending and negatively affect pharmaceutical companies' revenue and stock prices. Regulatory Changes: Changes in drug pricing regulations, patent laws, or healthcare policies can significantly impact AZN.ST's profitability and stock performance. Company Financial Performance: Revenue growth, profitability margins, earnings per share (EPS), and cash flow generation are key indicators of AZN.ST's financial health and can influence investor confidence.

People Also Watch

Latest news

Japan's Central Bank Poised for Rate Hike Amidst Heightened Middle East Tensions

Ava Grace|--

US Stocks Hit Record Highs as Geopolitical Fears Ease, Tech Bet Surge

Ava Grace|--

Fed Chair Succession Sparks Legal Battle Over Independence

Noah Lee|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Recommended Topics